Select Page

Valiant Laboratories IPO Detail 2023

Valiant Laboratories IPO Detail 2023


The Valiant Laboratories will open on September 27 and close on October 3, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 152.46 crore through this public offering, consisting of 10,890,000 shares with a face value of ₹ 10 each, which will be issued at a price of ₹ 133 to ₹ 140 per share.

Valiant Laboratories Limited (“the Company”)

Valiant Laboratories Limited was incorporated in 2021. The company is an active pharmaceutical ingredient (“API”)/bulk”drug manufacturing company with a focus on the manufacturing of paracetamol.

Bulk drugs and active pharmaceutical ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol (scientific name: Acetaminophen or para-hydroxyacetanilide, C8H9NO2) is one of the most commonly taken analgesics worldwide and is recommended as the first-line therapy for pain conditions by the World Health Organization (WHO).

Paracetamol has several applications, such as in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. They manufacture paracetamol in various grades, such as IP, BP, EP/USP, as per the pharmacopeia requirements of their customers.

Its manufacturing facility is located at Plot nos. L-13 and L-30, Tarapur Industrial Area, Boisar, Palghar, 401506, in the state of Maharashtra, India. Within its manufacturing facility, the company also has an in-house R&D infrastructure (“R&D Facility”).

Company Key Metrics

Earning Per Share (EPS)₹ 8.91 per Equity Share
Debt to Equity Ratio0.59
Return on Net Worth (RoNW)28.86%

Objects of the Issue,

  1. Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
  2. Investment in VASPL for funding its working capital requirements.
  3. General corporate purposes.

Financial Highlights (Restated)

ParticularsFY 2022-23FY 2021-22FY 2020-21
Net Worth100.4971.4688.58
Total Assets212.76181.81106.31
Total Borrowings59.4060.680.35
Total Revenue338.77293.47183.78
Profit After Tax29.0027.5030.59
(Amount in ₹ Lakhs)

IPO details

Issue TypeBook Built Issue IPO
IPO Price₹ 133 to ₹ 140 per share
Face Value₹ 10 per share
Market Lot105 Shares
Issue Size10,890,000 shares (aggregating up to ₹ 152.46 crores)
Fresh Issue10,890,000 shares (aggregating up to ₹ 152.46 crores)
Listing AtNSE, BSE

Shareholding Pattern

Shareholding pre-issue32,560,000
Shareholding post issue43,450,000

IPO Reservation

CategoriesNo. of shares offered
QIB shares offeredNot more than 50% of the net offer
NII (HNI) shares offeredNot less than 15% of the offer
Retail shares offeredNot less than 35% of the offer

GMP: Valiant Laboratories IPO

GMP, or grey market premium, is available on this page. The IPO GMP is updated on a day-to-day basis during the running period of the IPO, due to which the GMP rates fluctuate and stabilise after some time. GMP rates are not 100% guaranteed. Please click here for GMP details.

Tentative Dates: Valiant Laboratories IPO

The issue opens for subscription on September 27, 2023, and closes for subscription on October 3, 2023 (both days inclusive). The basis of allotment will be finalised on October 5, 2023, and the refunds will be initiated on October 6, 2023. In addition, the demat credits are expected to happen on October 6, 2023, and the stock will be listed on the NSE and BSE on October 9, 2023. The UPI mandate confirmation cut-off time is 5:00 PM on the issue closing day.

Opening DateSeptember 27, 2023
Closing DateOctober 3, 2023
Basis of AllotmentOctober 5, 2023
Initiation of RefundsOctober 6, 2023
A credit of shares to Demat A/cOctober 6, 2023
Listing DateOctober 9, 2023

Lot Size

The lot size of the Valiant Laboratories IPO is 105 shares. A retail-individual investor can apply for up to 13 lots, i.e. 1,365 shares of ₹ 191,100.

Retail (Minimum)1105₹ 14,700
Retail (Maximum)131,365₹ 191,100
S-HNI (Minimum)141,470₹ 205,800
S-HNI (Maximum)687,140₹ 999,600
B-HNI (Minimum)697,245₹ 1,014,300

Promoters Holdings 

Shantilal Shivji Vora and Dhanvallabh Ventures LLP (DVL) are the promoter of the company.

Pre-issue Shares Holdings100%
Post-issue Shares Holdings74.94%

Miscellaneous Information

Download Prospectus (PDF)IPO DRHP
Company Contact InformationValiant Laboratories Limited
104, Udyog Kshetra,Mulund Goregaon Link Road, Mulund West, Mumbai -400080
Phone: +91 2249712001
Email: [email protected]
IPO RegistrarLink Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
IPO Lead Manager(s)Unistone Capital Pvt Ltd

Leave a reply

Your email address will not be published. Required fields are marked *

Current IPO (Main Board)

Issuer CompanyOpenClose
Tata Technologies Ltd.--
Plaza Wires Ltd.29-Sep-234-Oct-23
Updater Services Ltd.25-Sep-2327-Sep-23
JSW Infrastructure ltd.25-Sep-2327-Sep-23
Yatra Online Ltd.15-Sep-2320-Sep-23


Issuer CompanyOpenClose
Rajgor Castor Derivatives Ltd.17-Oct-2320-Oct-23
WomanCart Ltd.16-Oct-2318-Oct-23
Committed Cargo Care Ltd.6-Oct-2310-Oct-23
Karnika Industries Ltd.29-Sep-234-Oct-23
Plada Infotech Services Ltd.29-Sep-234-Oct-23
Vivaa Tradecom Ltd.27-Sep-234-Oct-23